111 Capital’s Labcorp LH Stock Holding History

111 Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.6M	Buy	5,206 +3,318	+176%	+$1.03M	0.24%	98
2026 Q2	$529K	Buy	+1,888	New	+$496K	0.09%	227
2025 Q2	–	Sell	-1,685	Closed	-$392K	–	613
2025 Q1	$392K	Buy	+1,685	New	+$409K	0.08%	267

Other funds holding LH

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

111 Capital's LH Position: Q3 2026 in Review

111 Capital increased its Labcorp (LH) stake by 176% in Q3 2026, buying an estimated $1.03M and bringing the position to 5,206 shares worth $1.6M. The position accounts for 0.24% of the portfolio, ranked #98.

111 Capital first reported a position in LH in Q1 2025 and has held it in 3 quarters since. 549 funds tracked by Wall St. Rank hold LH as of Q3 2026.

111 Capital held 5,206 shares of Labcorp worth $1.6M as of Q3 2026.
111 Capital bought 3,318 Labcorp shares in Q3 2026, an estimated $1.03M.
Labcorp made up 0.24% of 111 Capital's portfolio in Q3 2026, its #98 holding.
111 Capital first reported a position in Labcorp in Q1 2025 and has held it in 3 quarters since.
549 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on 111 Capital's 13F filing for Q3 2026, filed 3 Nov 2026.